project id: TCGA-READ; case submitter id: TCGA-CL-5917; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 71; days to birth: -26084; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 26084; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2376.0; icd 10 code: C19; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Rectosigmoid junction; synchronous malignancy: No; tissue or organ of origin: Rectosigmoid junction; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 29.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.4; longest dimension: 0.5; oct embedded: No; shortest dimension: 0.4; portion submitter id: TCGA-CL-5917-01A-11; percent necrosis: 1.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 79.0; percent tumor nuclei: 80.0;